Navigation Links
Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer
Date:6/21/2013

New York, NY (PRWEB) June 21, 2013

On June 21, Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, announces that it has awarded Tocagen Inc. a grant to support the clinical investigation of Toca 511 & Toca FC in patients diagnosed with a recurrent high grade glioma brain cancer (Grade 3 or Grade 4).

Tocagen Inc., the clinical trial sponsor, is developing the investigational drug Toca 511 in combination with Toca FC for the treatment of recurrent high grade glioma, including glioblastoma multiforme (GBM, Grade IV glioma) which is the most common and aggressive form of brain cancer. Tocagen is a privately held biopharmaceutical company developing novel treatments for advanced cancer, with an initial focus on brain cancer. They are presently enrolling patients in its investigational Phase I clinical trials at leading clinical trial sites across the United States.

Harry Gruber, M.D., and the CEO of Tocagen says, “We are very appreciative to VABC for supporting our clinical trials in patients with recurrent brain cancer. We are encouraged with our clinical data and plan to present updates at a future scientific conference.”

“Every day, progress is made in the search for a cure for this devastating disease,” says Mario Lichtenstein, Co-founder of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy. “Toca 511 & Toca FC is a promising new approach in clinical trials that has the potential to help patients with brain cancer, and we are excited to provide support for this program.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations

Read the full story at http://www.prweb.com/releases/2013/6/prweb10853780.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Commends Family For Remaining Positive Despite Three Cancer Diagnoses
2. Voices Against Brain Cancer Commends Father of Nine for Running Marathons Despite Diagnosis
3. Voices Against Brain Cancer Commends Brain Cancer Survivor For His Positive Outlook
4. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
5. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
6. Voices Against Brain Cancer Commends Family for their Ongoing Efforts to Spread Brain Cancer Awareness
7. Avatar therapy helps silence voices in schizophrenia
8. Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells
9. Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle
10. Voices Against Brain Cancer Commends Mother for the Way She Honors Her Daughter’s Death
11. Voices Against Brain Cancer Applauds Mother For Starting Riah’s Rainbow Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... ... asset protection and financial planning services to families and business owners in the ... aimed at supporting children with developmental disabilities. , The Lakemary Center is a ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that Mr. Michael Merges, ... upcoming WCBP Conference, to be held at the Mayflower Hotel, Washington DC, on ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... the revolutionary Active Brake Technology (ABT), an innovative braking system that allows skaters ... Brake Technology addresses one of the biggest concerns of beginner and intermediate skaters ...
(Date:1/17/2017)... Michigan (PRWEB) , ... January 17, 2017 , ... January is National Stalking Awareness ... who choose to lurk in the corners and commit the crime of stalking, a very ... use and addiction, an often overlooked factor in stalking and other crimes. , “Stalking: know ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... point of difference. Eden Activewear is a stand-out company for several differences from ... online and only manufacture on demand, this is called 'Agile' manufacturing - ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, announces ... DMT210, in a Phase 2 acne rosacea study. ... downregulate the proinflammatory cytokines in the skin responsible ... rosacea. This clinical trial, DMT210-003, ...
(Date:1/18/2017)... Safe Rx LLC and Good Day Pharmacy, ... Loveland, Colorado , today announced the availability ... Day locations.     "Patients with prescriptions prone ... storage," said Milton Cohen , President & CEO ... a cup of coffee, you can protect your children ...
(Date:1/18/2017)... In China , we say Health is ... China,s Healthy Strategy originates. 2016 is ... and Social Development of the People,s Republic of ... council of the People,s Republic of China ... plan, identifying medical devices as one of the main breakthrough ...
Breaking Medicine Technology: